A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
7 analysts have issued ratings. Wall Street analysts rate MREO as Bullish on average, for a Wall Street consensus of buy. View MREO’s ratings here. What is Mereo BioPharma Group plc's stock price ...